A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients

Djura Piersma, Els Berns, M Verhoef-Post, André Uitterlinden, I Braakman, Huib Pols, Axel Themmen

Research output: Contribution to journalArticleAcademicpeer-review

49 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1470-1476
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number4
DOIs
Publication statusPublished - 2006

Cite this